CYP24A1 and myeloid sarcoma: In conclusion, the findings of this study suggest that vitamin D plus steroid has a therapeutic benefit on T cells in MS and NMOSD, and that differential transcriptional activities of the CYP24A1 gene could exist that affect serum 25(OH)D3 in MS.